BRAF mutation as a pejorative marker in metastatic melanoma.

被引：0
|
作者：
Brissy, Sophie
Gaudy-Marqueste, Caroline
Mallet, Stephanie
Monestier, Sandrine
Hesse, Sylvie
Koeppel, Marie-Christine
Rojat-Habib, Marie-Christine
Nanni, Isabelle
Loundou, Anderson
Ouafik, L'houcine
Bonnet, Nathalie
Richard, Marie-Aleth
Grob, Jean Jacques
机构：
[1] Aix Marseille Univ, Hop Timone, Marseille, France
[2] Aix Marseille Univ, Hop Nord, Marseille, France
[3] Aix Marseille Univ, Lab Transfert Biol, Marseille, France
[4] Aix Marseille Univ, Marseille, France
[5] Aix Marseille Univ, Timone Hosp, Marseille, France
[6] Aix Marseille Univ, Nord Hosp, Marseille, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8555
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Prognostic role of BRAF mutation in malignant cutaneous melanoma.
    Sehdev, Amikar
    Hayden, Ross
    Kuhar, Mathew Joseph
    Cheng, Liang
    Warren, Simon John
    Mark, Lawrence Aaron
    Wooden, William Arthur
    Schwartzentruber, Douglas Jay
    Logan, Theodore F.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [2] Outcomes following progression on BRAF/MEK inhibition in metastatic melanoma.
    Mason, Robert
    Heng, Sharon
    Atkinson, Victoria
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [3] Impact of BRAF mutation in patients with brain metastasis from melanoma.
    Venur, Vyshak Alva
    Kotecha, Rupesh
    Chen, Zhijian
    Chao, Samuel T.
    Elson, Paul
    Suh, John H.
    Ahluwalia, Manmeet Singh
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [4] BRAF-Mutation detection in metastatic Melanoma
    Dietel, M.
    Enk, A.
    Lehmann, A.
    Bauer, J.
    Garbe, C.
    Kellner, U.
    Kirchner, T.
    Jung, A.
    Kreipe, H.
    Merkelbach-Bruse, S.
    Buettner, R.
    Rueschoff, J.
    Schlake, W.
    Schirmacher, P.
    Penzel, R.
    Stadler, R.
    [J]. PATHOLOGE, 2012, 33 (04): : 352 - 356
  • [5] Analysis of BRAF mutation in primary and metastatic melanoma
    Libra, M
    Malaponte, G
    Navolanic, PM
    Gangemi, P
    Bevelacqua, V
    Proietti, L
    Bruni, B
    Stivala, F
    Mazzarino, MC
    Travali, S
    McCubrey, JA
    [J]. CELL CYCLE, 2005, 4 (10) : 1382 - 1384
  • [6] BRAF and NRAS mutation status and response to checkpoint inhibition in advanced melanoma.
    van Not, Olivier Jules
    van den Eertwegh, Alfonsus Johannes Maria
    Haanen, John B. A. G.
    Blank, Christian U.
    Aarts, Maureen J. B.
    van den Berkmortel, Franchette
    de Groot, Jan Willem
    Hospers, Geke
    Kapiteijn, Ellen
    Piersma, Djura
    Van Rijn, Rozemarijn
    Stevense, Marion
    Van Der Veldt, Astrid Aplonia Maria
    Vreugdenhil, Gerard
    Boers-Sonderen, Marye
    Bonenkamp, Han J.
    Jansen, Anne M. L.
    Blokx, Willeke
    Wouters, Michel W. J. M.
    Suijkerbuijk, Karijn
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [7] Inhibition of Mutated BRAF in Melanoma.
    Kim, Taegyun
    Kim, Jihyun
    Lee, Min-Geol
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (23): : 2261 - 2261
  • [8] BRAF Mutation-Positive Folliculotropic Metastatic Melanoma
    Brick, Katherine E.
    Halling, Kevin C.
    Khan, Yulia K.
    Peters, Margot S.
    [J]. AMERICAN JOURNAL OF DERMATOPATHOLOGY, 2013, 35 (05) : 609 - 612
  • [9] Targeting BRAF by siRNA in human melanoma.
    Liang, YZ
    Gawad, C
    Azorsa, D
    Walker, R
    Meltzer, PS
    [J]. CLINICAL CANCER RESEARCH, 2003, 9 (16) : 6096S - 6096S
  • [10] International comparison of BRAF testing in melanoma.
    dos Santos, Marcos Tadeu
    Atkey, Neil
    Aita, Eloise
    Clark, Jordan
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
12345